NYSE:PHG - Koninklijke Philips Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $51.00
  • Forecasted Upside: -1.26 %
  • Number of Analysts: 11
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$51.65
▲ +0.9 (1.77%)
1 month | 3 months | 12 months
Get New Koninklijke Philips Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$51.00
▼ -1.26% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Koninklijke Philips in the last 3 months. The average price target is $51.00, with a high forecast of $51.00 and a low forecast of $51.00. The average price target represents a -1.26% upside from the last price of $51.65.
Buy
The current consensus among 11 polled investment analysts is to buy stock in Koninklijke Philips. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 1 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 1 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/12/2020Berenberg BankReiterated RatingBuyLow
i
10/29/2020Morgan StanleyReiterated RatingOverweightLow
i
10/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
10/20/2020UBS GroupReiterated RatingBuyLow
i
10/20/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
10/2/2020UBS GroupReiterated RatingBuyLow
i
9/23/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
9/23/2020BarclaysReiterated RatingOverweightLow
i
9/3/2020JPMorgan Chase & Co.Reiterated RatingNeutralHigh
i
9/1/2020UBS GroupReiterated RatingBuyMedium
i
8/27/2020Societe GeneraleDowngradeSellLow
i
7/28/2020Societe GeneraleInitiated CoverageBuyMedium
i
7/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
7/9/2020Morgan StanleyReiterated RatingOverweightLow
i
6/22/2020BarclaysReiterated RatingOverweightLow
i
4/22/2020Morgan StanleyReiterated RatingOverweightLow
i
4/21/2020JPMorgan Chase & Co.Reiterated RatingNeutralMedium
i
4/19/2020Kepler Capital MarketsReiterated RatingHoldHigh
i
4/7/2020JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
3/23/2020DZ BankReiterated RatingHold ➝ BuyHigh
i
3/23/2020UBS GroupReiterated RatingBuyLow
i
3/10/2020Kepler Capital MarketsReiterated RatingHoldMedium
i
2/10/2020UBS GroupReiterated RatingBuyLow
i
1/21/2020Roth CapitalReiterated RatingBuyMedium
i
Rating by Craig Irwin at Roth Capital
1/13/2020Bank of AmericaBoost Price TargetBuy$45.00 ➝ $51.00Low
i
12/6/2019Morgan StanleyUpgradeEqual Weight ➝ OverweightMedium
i
10/28/2019Berenberg BankReiterated RatingBuyMedium
i
10/7/2019Berenberg BankReiterated RatingBuyLow
i
8/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
7/30/2019CitigroupInitiated CoverageBuy ➝ BuyLow
i
10/2/2018Credit Suisse GroupDowngradeOutperform ➝ NeutralLow
i
9/18/2018Exane BNP ParibasUpgradeNeutral ➝ OutperformLow
i
9/17/2018BNP ParibasUpgradeHold ➝ BuyLow
i
9/13/2018Sanford C. BernsteinInitiated CoverageOutperformLow
i
4/17/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
i
2/12/2018Berenberg BankUpgradeHold ➝ BuyLow
i
11/9/2017JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralN/A
i
10/24/2017CitigroupReiterated RatingBuyN/A
i
10/16/2017BNP ParibasDowngradeOutperform ➝ NeutralN/A
i
7/24/2017JPMorgan Chase & Co.Reiterated RatingBuyLow
i
7/3/2017Canaccord GenuityReiterated RatingBuy$37.00Low
i
6/21/2017NatixisDowngradeBuy ➝ NeutralLow
i
6/20/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldMedium
i
4/25/2017Societe GeneraleDowngradeBuy ➝ HoldLow
i
3/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyLow
i
2/7/2017Berenberg BankInitiated CoverageHoldN/A
i
1/26/2017CitigroupReiterated RatingBuyN/A
i
12/12/2016Morgan StanleyDowngradeOverweight ➝ Equal WeightN/A
i
11/23/2016CitigroupInitiated CoverageBuyN/A
i
10/24/2016Credit Suisse GroupReiterated RatingBuy$30.00N/A
i
8/10/2016UBS GroupUpgradeNeutral ➝ BuyN/A
i
5/11/2016BNP ParibasUpgradeNeutral ➝ OutperformN/A
i
5/1/2016Credit Suisse GroupReiterated RatingBuyN/A
i
3/21/2016Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyN/A
i
2/16/2016Jefferies Financial GroupDowngradeHold ➝ UnderperformN/A
i
1/27/2016The Goldman Sachs GroupReiterated RatingBuyN/A
i
12/4/2015JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
(Data available from 11/28/2015 forward)
Koninklijke Philips logo
Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, and diagnostic X-ray, as well as integrated clinical solutions; interventional X-ray systems, including cardiovascular, radiology and surgery, and interventional imaging and therapy devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation solutions; data, analytics, and actionable workflow products; and connected care informatics solutions. In addition, it provides power toothbrushes; infant feeding and digital parental solutions; male grooming and beauty products; and kitchen appliances, home care, garment care, and coffee products. Further, the company offers digital frameworks that connect consumers, patients, healthcare providers, payers, and partners in a cloud-based connected health ecosystem of solutions, products, systems, services, and devices. It has a strategic collaboration with BioIntelliSense to integrate BioSticker medical device into the company's remote patient monitoring offering to help monitor at-risk patients from the hospital into the home; and a collaboration with Singapore General Hospital to establish the digital and computational pathology center of excellence. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Read More

Today's Range

Now: $51.65
$51.27
$51.76

50 Day Range

MA: $50.00
$46.50
$53.44

52 Week Range

Now: $51.65
$30.50
$54.28

Volume

96,744 shs

Average Volume

821,544 shs

Market Capitalization

$46.97 billion

P/E Ratio

36.63

Dividend Yield

1.83%

Beta

0.9